The Access to Medicine Foundation has released a report highlighting how generic medicine manufacturers are addressing Africa's changing healthcare needs. The report focuses on the rising demand for treatments for non-communicable diseases such as diabetes, cardiovascular diseases, and cancer. It warns that only one in two people living with type 1 diabetes in Africa has reliable access to insulin. The findings were presented during a virtual press briefing, underscoring the challenges facing health systems in ensuring essential medicines reach patients.
Related Articles
Don't miss out on breaking stories and in-depth articles.